Rajesh Devraj - Concepedia

Author

Rajesh Devraj

Pfizer (United States)

Also Known As

R Devraj, R V Devraj, R. DEVRAJ, R. Devraj, R. V. DEVRAJ, Rajesh Devraj, Rajesh V Devraj, Rajesh V. Devraj

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Duquesne University Eli Lilly (United States)Experimental Station Purdue University West Lafayette

About

Rajesh Devraj is an author at Pfizer (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.3K
2	Natural Sciences	8	8	227
3	Biochemistry	7	7	210
4	Biomolecular Engineering	4	4	88
5	Engineering	3	3	176

Rajesh Devraj

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Physiochemical drug properties associated with in vivo toxicological outcomes Jason D. Hughes, Julian Blagg, David A. Price, Bioorganic & Medicinal Chemistry Letters Preclinical Drug EvaluationMedicineToxicologyClinical ToxicologyPharmacology	2008	945
Chemical Library Purification Strategies Based on Principles of Complementary Molecular Reactivity and Molecular Recognition Daniel L. Flynn, J. Z. CRICH, Rajesh Devraj, Journal of the American Chemical Society	1997	211
Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate Robert Hughes, Todd Bosanac, Xianrong Mao, Cell Reports	2021	175
Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy Todd Bosanac, Robert Hughes, Thomas M. Engber, Brain	2021	144
cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons Yo Sasaki, Thomas M. Engber, Robert Hughes, Experimental Neurology Molecular NeuroscienceEngineeringMedicineBiomarker TargetDegenerative Disease	2020	116
Classical and Nonclassical Furo[2,3-d]pyrimidines as Novel Antifolates: Synthesis and Biological Activities Aleem Gangjee, Rajesh Devraj, John J. McGuire, Journal of Medicinal Chemistry	1994	70
Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase Shaun R. Selness, Rajesh Devraj, Balekudru Devadas, Bioorganic & Medicinal Chemistry Letters Drug TargetSignaling PathwayP38 Map KinaseBiochemistryPotent Inhibitor	2011	70
Synthesis, Crystal Structure, and Activity of Pyrazole-Based Inhibitors of p38 Kinase Matthew J. Graneto, Ravi G. Kurumbail, Michael L. Vazquez, Journal of Medicinal Chemistry	2007	64
Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines Aleem Gangjee, Rajesh Devraj, John J. McGuire, Journal of Medicinal Chemistry	1995	63
Anti-Inflammatory Properties of a Novel N-Phenyl Pyridinone Inhibitor of p38 Mitogen-Activated Protein Kinase: Preclinical-to-Clinical Translation Heidi R. Hope, Gary D. Anderson, Barry Burnette, Journal of Pharmacology and Experimental Therapeutics	2009	60

Page 1